Authors:
ORTEL TL
MOORE KD
QUINNALLEN MA
OKAMURA T
SINCLAIR AJ
LAZARCHICK J
GOVINDAN R
CARMAGNOL F
KANE WH
Citation: Tl. Ortel et al., INHIBITORY ANTI-FACTOR-V ANTIBODIES BIND TO THE FACTOR-V C2 DOMAIN AND ARE ASSOCIATED WITH HEMORRHAGIC MANIFESTATIONS, Blood, 91(11), 1998, pp. 4188-4196
Citation: Cj. Wei et al., PROTEIN-S SELECTIVELY ACCELERATES THE APC CATALYZED CLEAVAGE AT BOTH ARGININE-306 AND ARGININE-679 IN FACTOR VA, Blood, 90(10), 1997, pp. 638-638
Citation: Cj. Wei et al., ACTIVATED PROTEIN-C CATALYZED CLEAVAGE OF FACTOR-V AT ARGININE-506 RESULTS IN PARTIAL INACTIVATION OF THE COFACTOR, Journal of investigative medicine, 44(3), 1996, pp. 214-214
Citation: Tl. Ortel et al., FACTOR-V INHIBITORS ASSOCIATED WITH HEMORRHAGIC SYMPTOMS BIND TO A LIMITED REGION OF THE FACTOR VA LIGHT-CHAIN, Journal of investigative medicine, 44(3), 1996, pp. 233-233
Authors:
DARROW TL
ABDELWAHAB Z
QUINNALLEN MA
SEIGLER HF
Citation: Tl. Darrow et al., RECOGNITION AND LYSIS OF HUMAN-MELANOMA BY A CD3(-) T-CELL CLONE RESTRICTED BY HLA-A2(), CD4(+), CD8(), Cellular immunology, 172(1), 1996, pp. 52-59
Citation: Cj. Wei et al., SYSTEMATIC MUTAGENESIS OF ACTIVATED PROTEIN-C CLEAVAGE SITES IN FACTOR VA DEMONSTRATES THAT MULTIPLE CLEAVAGES ARE REQUIRED FOR COMPLETE INACTIVATION OF THE COFACTOR, Blood, 88(10), 1996, pp. 1751-1751
Citation: Cj. Wei et al., CLEAVAGE AT ARGININE-306 IS NOT REQUIRED FOR INACTIVATION OF FACTOR-VBY ACTIVATED PROTEIN-C (APC), Blood, 86(10), 1995, pp. 2446-2446
Authors:
ORTEL TL
QUINNALLEN MA
KELLER FG
PETERSON JA
LAROCCA D
KANE WH
Citation: Tl. Ortel et al., LOCALIZATION OF FUNCTIONALLY IMPORTANT EPITOPES WITHIN THE 2ND C-TYPEDOMAIN OF COAGULATION-FACTOR V USING RECOMBINANT CHIMERAS, The Journal of biological chemistry, 269(22), 1994, pp. 15898-15905
Citation: Tl. Ortel et al., PURIFICATION AND CHARACTERIZATION OF THE 2ND C-TYPE DOMAIN OF HUMAN FACTOR-V EXPRESSED IN BACULOVIRUS, Blood, 84(10), 1994, pp. 10000387-10000387
Citation: Tl. Ortel et al., PARTIAL GLYCOSYLATION AT ASPARAGINE-2181 OF THE 2ND C-TYPE DOMAIN OF HUMAN FACTOR-V IS THE STRUCTURAL BASIS OF THE LIGHT-CHAIN DOUBLET, Blood, 84(10), 1994, pp. 10000387-10000387
Citation: Tl. Ortel et al., A FACTOR-V FACTOR-VIII LIGHT-CHAIN CHIMERA THAT EXPRESSES FACTOR-V PROCOAGULANT ACTIVITY AND IS RESISTANT TO NEUTRALIZATION BY A FACTOR-V INHIBITOR, Thrombosis and haemostasis, 69(6), 1993, pp. 1046-1046
Citation: Fg. Keller et al., FUNCTIONAL-CHARACTERIZATION OF THROMBIN CLEAVAGE SITES IN HUMAN COAGULATION FACTOR-V USING SITE-DIRECTED-MUTAGENESIS, Blood, 82(10), 1993, pp. 10000338-10000338